Daily Mail on MSN

Hope for thousands as new drug cuts prostate cancer relapse risk by a third

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...

J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the cancer and reduced the risk of ...

Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades ...

Johnson & Johnson (NYSE:JNJ) today announced results from the final analysis of the Phase 3 PROTEUS study showing the investigational use of apalutamide plus hormone therapy (androgen deprivation ...
MedPage Today

Video: Treatment for Advanced Prostate Cancer and Competing Causes of Death (0:57)

Intensifying Hormonal Therapy for Patients with Advanced Prostate Cancer: Overcoming the Challenges What are the 3 Most Important Considerations When Individualizing Treatment for Patients with ...
WPBF

Men's Health Awareness: Advanced treatment for prostate cancer

ABOUT IT. PROSTATE CANCER. IT CAN BE A TOPIC MANY OF US TRY TO AVOID, ESPECIALLY WHEN IT COMES TO HOW YOU HAVE TO SCREEN FOR IT. BUT DURING THIS NATIONAL MEN’S HEALTH AWARENESS MONTH, DOCTORS HAVE A ...

Blood test spots failing prostate cancer treatment within 6-12 weeks, study finds

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...
WLNS.com

New Treatment Option Is Helping Patients with Advanced Prostate Cancer

Prostate cancer has become a significant health concern among men, being the second leading cause of death in the United States. While the survival rate in men remains high, those who have advanced, ...
Case Western Reserve University

Researchers develop treatment for advanced prostate cancer that could eliminate severe side effects

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...
phillyvoice.com

Prostate cancer therapy being tested at Main Line Health may 'open up the door' to new treatments for advanced cancers

Prostate cancer that has spread to other parts of the body has limited treatment options, but a biomedical research group affiliated with Main Line Health has begun investigating a new therapy for ...

Prostate cancer patients left navigating ‘knowledge gap’ over treatment options

Prostate cancer is the most commonly diagnosed cancer in the UK, with more than 63,000 new cases each year. Yet for many men, understanding their treatment options remains far from straightforward ...
The Manila Times

Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, versus hormone ...

Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20 percent reduction in the ris ...